Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies

Background: Although immunotherapy with checkpoint inhibitors is changing the face of lung adenocarcinoma (LUAD) treatments, only limited patients could benefit from it. Therefore, we aimed to develop an immune-relevant-gene-based signature to predict LUAD patients' prognosis and to characteriz...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Liang, Bi, Guoshu, Zhan, Cheng, Zhang, Yi, Yuan, Yunfeng, Fan, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267039/
https://www.ncbi.nlm.nih.gov/pubmed/32537435
http://dx.doi.org/10.3389/fonc.2020.00835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267039/
https://www.ncbi.nlm.nih.gov/pubmed/32537435
http://dx.doi.org/10.3389/fonc.2020.00835

Ejemplares similares